Forge Therapeutics acquired spinoff Blacksmith Medicines while solar film producer Sinopont raised $145m in series D funding.
M&A
Antibiotic drug provider Forge Therapeutics has agreed to pay an undisclosed amount to acquire Blacksmith Medicines, a US-based inflammatory diseases therapy developer spun off by the corporate in early 2021. It had received an undisclosed amount of seed financing from investors including pharmaceutical companies Eli Lilly and Evotec as well as Alexandria Venture Investments, a subsidiary of life sciences real estate investment trust Alexandria Real Estate Equities.
Meta, the owner of social media platforms Facebook and Instagram, has bought Luxexcel, a Netherlands-based smart eyewear provider that counts process control equipment manufacturer KLA Tencor, for an undisclosed amount, De Tijd has reported. The corporate invested through a series C round which stood at $16.4m as of 2017, lifting Luxexcel’s total funding to over $24m.
Fund
KuCoin Labs, the Seychelles-based incubation and research subsidiary…
